Speaking Engagements
Healthcare Securities Class Actions, SEC Enforcement & Emerging Capital Markets Risks
September 2, 2026
Thursday, December 5 • 8:00 a.m. – 4:00 p.m. ET
Troutman Pepper and Locke Lord are excited to invite you to our Annual Antitrust CLE event, where U.S. and international presenters will offer an in-depth look at significant antitrust developments and provide practical guidance to help you minimize and manage risks.
The event will feature five panels (4.5 hours substantive and 1 hour ethics). The panels will encourage audience participation and engagement with our distinguished group of presenters. Panelists will cover current non-merger and merger enforcement, potential changes under the next administration, and recent international competition law developments. Discussions will also cover the impact of recent unilateral conduct guidance, the antitrust risks that arise working with vendors or other intermediaries, and questions about professional responsibility rules and licensing in the legal profession.
8:00 a.m. | Registration and Breakfast
8:30 a.m. | Opening Remarks
8:35 a.m. | Where Do We Stand Now and What Could the Next Administration Bring?
Our panelists will consider whether the agencies have followed through on a variety of non-merger conduct and whether companies will need to continue to be focused on such behavior. Whether the Robinson-Patman Act is really back? Does the FTC’s effort to ban non-competes end with the presidential election? Will Section 5 Policy Statement’s “coercive, exploitative, collusive, abusive, deceptive, predatory” standard survive? Whether DOJ has defined a Section 2 criminal violation?
9:35 a.m. | International Transactions
An experienced panel of international competition law attorneys will discuss the latest developments in Canada, Europe, and the United States and the practical implications of those developments. The panel will also consider how political change might impact transactions.
11:15 a.m. | The “Dreaded” Intermediaries
U.S. antitrust enforcement agencies have been increasingly critical of the role of intermediaries in the economy. This panel of experienced antitrust lawyers will discuss the growing antitrust risks of working with the vendors or intermediaries, from artificial intelligence and software to benchmarking, group purchasing organizations and pharmacy benefits managers. Is transparency good or bad and how can advisors reduce the antitrust risk of working with intermediaries?
12:15 p.m. | Networking Lunch
1:00 p.m. | Unilateral Conduct: Companies in the Danger Zone?
U.S. and international antitrust attorneys will discuss how recent guidance from antitrust authorities and the courts shifted how companies face refusal to deal, exclusivity, tying, and other potential exclusionary conduct.
2:10 p.m. | Ethics – The Legal Profession’s Monopoly
Do the professional responsibility rules and licensing requirements perpetuate injustice?
3:10 p.m. | Networking Reception
This just in
Speaking Engagements
Healthcare Securities Class Actions, SEC Enforcement & Emerging Capital Markets Risks
September 2, 2026
Speaking Engagements
PFAS for Decision Makers: Managing PFAS Risk in Today’s Deals – While Preparing for What’s Next
August 27, 2026 | 12:00 PM – 1:00 PM CT
Webinar
Firm Events
Cocktails and Networking During MEDevice Boston
August 26, 2026 | 6:00 PM – 8:00 PM ET
Lifted Restaurant
450 Summer St, Boston, MA 02210
Speaking Engagements
The 2026 Multifamily Maturity Cliff: Reading the $162 Billion Refinancing Wave and the Engagements It Will Generate
August 26, 2026 | 1:00 PM – 3:10 PM ET
Webinar